Literature DB >> 7568039

Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.

K W Wucherpfennig1, D A Hafler, J L Strominger.   

Abstract

T-cell receptors (TCRs) recognize peptide bound within the relatively conserved structural framework of major histocompatibility complex (MHC) class I or class II molecules but can discriminate between closely related MHC molecules. The structural basis for the specificity of ternary complex formation by the TCR and MHC/peptide complexes was examined for myelin basic protein (MBP)-specific T-cell clones restricted by different DR2 subtypes. Conserved features of this system allowed a model for positioning of the TCR on DR2/peptide complexes to be developed: (i) The DR2 subtypes that presented the immunodominant MBP peptide differed only at a few polymorphic positions of the DR beta chain. (ii) TCR recognition of a polymorphic residue on the helical portion of the DR beta chain (position DR beta 67) was important in determining the MHC restriction. (iii) The TCR variable region (V) alpha 3.1 gene segment was used by all of the T-cell clones. TCR V beta usage was more diverse but correlated with the MHC restriction--i.e., with the polymorphic DR beta chains. (iv) Two clones with conserved TCR alpha chains but different TCR beta chains had a different MHC restriction but a similar peptide specificity. The difference in MHC restriction between these T-cell clones appeared due to recognition of a cluster of polymorphic DR beta-chain residues (DR beta 67-71). MBP-(85-99)-specific TCRs therefore appeared to be positioned on the DR2/peptide complex such that the TCR beta chain contacted the polymorphic DR beta-chain helix while the conserved TCR alpha chain contacted the nonpolymorphic DR alpha chain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568039      PMCID: PMC41074          DOI: 10.1073/pnas.92.19.8896

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  The T lymphocyte in experimental allergic encephalomyelitis.

Authors:  S S Zamvil; L Steinman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 2.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

3.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

4.  Predictable acquisition of a new MHC recognition specificity following expression of a transfected T-cell receptor beta-chain gene.

Authors:  T Saito; R N Germain
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

5.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

6.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

7.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

Authors:  R Martin; D Jaraquemada; M Flerlage; J Richert; J Whitaker; E O Long; D E McFarlin; H F McFarland
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

8.  Sequences and repertoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes.

Authors:  N Kimura; B Toyonaga; Y Yoshikai; R P Du; T W Mak
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

9.  Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide.

Authors:  K W Wucherpfennig; J Zhang; C Witek; M Matsui; Y Modabber; K Ota; D A Hafler
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

10.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.

Authors:  K W Wucherpfennig; A Sette; S Southwood; C Oseroff; M Matsui; J L Strominger; D A Hafler
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  13 in total

1.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from Actinomyces.

Authors:  Qiu-Hua Gu; Megan Huynh; Yue Shi; Xiao-Yu Jia; Jie-Jian Luo; Tai-Jiao Jiang; Zhao Cui; Joshua D Ooi; A Richard Kitching; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2020-06       Impact factor: 10.121

3.  Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens.

Authors:  A Matsuo; G C Lee; K Terai; K Takami; W F Hickey; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Positioning of autoimmune TCR-Ob.2F3 and TCR-Ob.3D1 on the MBP85-99/HLA-DR2 complex.

Authors:  Zenichiro Kato; Joel N H Stern; Hironori K Nakamura; Kazuo Kuwata; Naomi Kondo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-29       Impact factor: 11.205

5.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

6.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

7.  Is multiple sclerosis an autoimmune disease?

Authors:  Bharath Wootla; Makoto Eriguchi; Moses Rodriguez
Journal:  Autoimmune Dis       Date:  2012-05-16

8.  Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.

Authors:  M Krogsgaard; K W Wucherpfennig; B Cannella; B E Hansen; A Svejgaard; J Pyrdol; H Ditzel; C Raine; J Engberg; L Fugger; B Canella
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

9.  Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis.

Authors:  Stephanie Day; Theodore Tselios; Maria-Eleni Androutsou; Anthi Tapeinou; Irene Frilligou; Lily Stojanovska; John Matsoukas; Vasso Apostolopoulos
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

10.  Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity.

Authors:  Amedeo Amedei; Mathijs P Bergman; Ben J Appelmelk; Annalisa Azzurri; Marisa Benagiano; Carlo Tamburini; Ruurd van der Zee; John L Telford; Christina M J E Vandenbroucke-Grauls; Mario M D'Elios; Gianfranco Del Prete
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.